Zylox-Tonbridge Medical Technology Co., Ltd. (FRA:818)

FRA:818 Statistics

Total Valuation

FRA:818 has a market cap or net worth of EUR 903.27 million. The enterprise value is 717.88 million.

Market Cap	903.27M
Enterprise Value	717.88M

Important Dates

The last earnings date was Wednesday, November 19, 2025.

Earnings Date	Nov 19, 2025
Ex-Dividend Date	Jun 4, 2025

Share Statistics

Current Share Class	329.60M
Shares Outstanding	n/a
Shares Change (YoY)	-0.26%
Shares Change (QoQ)	-0.92%
Owned by Insiders (%)	17.30%
Owned by Institutions (%)	21.54%
Float	179.77M

Valuation Ratios

The trailing PE ratio is 49.80 and the forward PE ratio is 31.97.

PE Ratio	49.80
Forward PE	31.97
PS Ratio	8.46
PB Ratio	2.41
P/TBV Ratio	2.43
P/FCF Ratio	74.36
P/OCF Ratio	33.99
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 42.62, with an EV/FCF ratio of 59.10.

EV / Earnings	39.58
EV / Sales	6.60
EV / EBITDA	42.62
EV / EBIT	59.29
EV / FCF	59.10

Financial Position

The company has a current ratio of 5.77, with a Debt / Equity ratio of 0.03.

Current Ratio	5.77
Quick Ratio	5.09
Debt / Equity	0.03
Debt / EBITDA	0.60
Debt / FCF	0.81
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 4.87% and return on invested capital (ROIC) is 1.95%.

Return on Equity (ROE)	4.87%
Return on Assets (ROA)	1.79%
Return on Invested Capital (ROIC)	1.95%
Return on Capital Employed (ROCE)	3.15%
Revenue Per Employee	122,048
Profits Per Employee	20,728
Employee Count	875
Asset Turnover	0.26
Inventory Turnover	1.28

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +110.85% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+110.85%
50-Day Moving Average	2.64
200-Day Moving Average	2.25
Relative Strength Index (RSI)	51.22
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:818 had revenue of EUR 106.79 million and earned 18.14 million in profits. Earnings per share was 0.06.

Revenue	106.79M
Gross Profit	76.32M
Operating Income	11.89M
Pretax Income	18.14M
Net Income	18.14M
EBITDA	15.98M
EBIT	11.89M
Earnings Per Share (EPS)	0.06

Balance Sheet

The company has 191.96 million in cash and 9.88 million in debt, giving a net cash position of 182.08 million.

Cash & Cash Equivalents	191.96M
Total Debt	9.88M
Net Cash	182.08M
Net Cash Per Share	n/a
Equity (Book Value)	374.97M
Book Value Per Share	1.15
Working Capital	183.06M

Cash Flow

In the last 12 months, operating cash flow was 26.57 million and capital expenditures -14.42 million, giving a free cash flow of 12.15 million.

Operating Cash Flow	26.57M
Capital Expenditures	-14.42M
Free Cash Flow	12.15M
FCF Per Share	n/a

Margins

Gross margin is 71.47%, with operating and profit margins of 11.13% and 16.98%.

Gross Margin	71.47%
Operating Margin	11.13%
Pretax Margin	16.98%
Profit Margin	16.98%
EBITDA Margin	14.97%
EBIT Margin	11.13%
FCF Margin	11.38%

Dividends & Yields

This stock pays an annual dividend of 0.01, which amounts to a dividend yield of 0.45%.

Dividend Per Share	0.01
Dividend Yield	0.45%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	21.10%
Buyback Yield	0.26%
Shareholder Yield	0.71%
Earnings Yield	2.01%
FCF Yield	1.34%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:818 has an Altman Z-Score of 7.95 and a Piotroski F-Score of 6.

Altman Z-Score	7.95
Piotroski F-Score	6